Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
GLP-1 receptor agonists, widely used for managing type 2 diabetes and obesity, represented over $14 billion in Medicare Part D spending from November 2023 to October 2024, underscoring their significant financial impact on the program
Despite countless diets, exercise routines, and supplements, the results often fall short
Consistent, daily use for several weeks or months typically yields far better and more lasting results than sporadic application
Key findings from the SURMOUNT studies include: In SURMOUNT-1, participants on the highest dose of Zepbound (15 mg) lost 21% of their body weight (about 52 pounds) from an average starting weight of 231 pounds
Retatrutide Key Health Benefits: Supports weight loss Helps preserve lean muscle Reduce food cravings Aids metabolic health Lowers blood pressure Improves blood sugar control Need supplies
US$ 25.12
US$ 21.71
US$ 25.43
US$ 23.39
